RxDoctor Payments Data

Rebecca Duff, MD

Dermatology · Hattiesburg, MSNPI 1346377769

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 48.8% of the total. Reporting peaked in 2024 at $299 and has fallen 93.5% since, to $19 in 2025. That places this record below the midpoint for dermatology clinicians in MS, where the typical reported total is $4,621.

$1,242in general payments, 2019–2025

Across 71 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$606
  • Revance Therapeutics, Inc.$88
  • Sun Pharmaceutical Industries Inc.$75
  • Novartis$66
  • Galderma Laboratories, L.p.$59
  • Hill Dermaceuticals, Inc.$41
  • plus $306 from 16 others

What the payments were for

  • Food & beverage$1,242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,242 in reported general payments places this provider in the 25th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi

Medicare billing

Part B allowed, 2024
$136,318
Medicare patients
646
Services billed
3,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole23$1,774
Betamethasone Dipropionate59$1,684
Ketoconazole109$1,589
Fluorouracil15$827
Clindamycin Phosphate21$799
Doxycycline Monohydrate35$364
Nystatin31$278
Mupirocin31$248
CiclopiroxCiclopirox Olamine14$170
Triamcinolone Acetonide44$161
Hydrocortisone16$58
ValacyclovirValacyclovir Hcl13$52

Paid to pharmacies, not to this prescriber.

Other dermatology in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →